Who We Are
What We Do
For Patients
What's New
Evaluation and Diagnosis
• In-Office Ultrasound
• Mammography
• PEM Scan
Breast Biopsy
Benign Conditions of the Breast
• Breast Pain
• Cyst Aspiration
High Risk Evaluation
• Risk Factors for
   Breast Cancer

• Genetic Testing
• Lobular Carcinoma
   In Situ
Care of the Breast Cancer Patient

• After Surgical Treatment
  of Breast Cancer
• Lumpectomy
• Mastectomy
• Sentinel Node Biopsy
• Axillary Lymph Node
• Lymphedema
• Breast Reconstruction
• Radiation Therapy

Print this information
High Risk Evaluation
Genetic Testing

Ten percent of all breast and ovarian cancers are hereditary. The majority of heredity and ovarian cancer is due to a mutation in either the BRCA1 or BRCA2 genes. These mutations can be inherited from either your mother or father. Individuals who are found to be positive for either the BRCA 1 or BRCA 2 carry an increased risk for breast cancer of approximately 87% and approximately 44% for ovarian cancer (Myriad, 2004).

Individuals who should consider genetic testing are those with a personal or family history of:
Breast cancer before age 50
Ovarian cancer at any age
Bilateral breast cancer
Male breast cancer
Relatives of a BRCA mutation carrier

Once an individual is identified who might benefit from genetic counseling we refer them to a healthcare provider available in our office, who will have a thorough discussion about what genetic counseling means, some of the potential recommendations for treatment, or follow-up for individuals who test positive for the gene mutation. Testing is done by drawing a blood sample which is sent to a special lab. The results usually are back within 2 – 3 weeks. Some but not all health insurance policies will cover the testing. You should always check with your insurance provider first before having the test as it can be expensive.

Print this information
© 2005 The Center for Advanced Breast Care info@AdvancedBreastCare.net Disclaimer